Clinical Research, Pharma & Healthcare Financing

Daiichi Sankyo Names New Head of Translational Research Europe

Daiichi Sankyo Names New Head of Translational Research Europe

Daiichi Sankyo (TSE:4568) has appointed Veronika Rozehnal, Ph.D., to succeed Jürgen Müller, Ph.D., as the Head of the Translational Research Center Europe.

Dr. Jürgen Müller will retire after nearly 30 years of research work at Daiichi Sankyo. Under his leadership, the Translational Research Center Europe, previously called the Tissue and Cell Research Center Munich, has grown from three to 40 researchers since it was founded in 1997 and has become an internationally recognized institution that plays a strategic role in the global innovation process of Daiichi Sankyo.

Dr. Veronika Rozehnal joined Daiichi Sankyo in 2009 and has held various positions at the Translational Research Center Europe in addition to spending three years at the Daiichi Sankyo R&D Center in Tokyo. Dr. Rozehnal graduated from Ernst-Moritz-Arndt University of Greifswald, Germany with a Ph.D. degree in Clinical Pharmacology.

“Jürgen Müller has made significant scientific contributions that have helped Daiichi Sankyo transform into a global research focused company, including developing new approaches to better evaluate and understand mechanisms of action to create new medicines for patients. We thank him sincerely for his many years of commitment and wish him all the best for the future,” said Yuki Abe, Ph.D., Head of R&D Division in Japan and Head of Research, Daiichi Sankyo. “We are confident that with her extensive experience, Veronika Rozehnal will continue to provide strong leadership within the research organization at Daiichi Sankyo, helping to further establish the presence of Daiichi Sankyo research in Europe.”

“I look back with great gratitude on many years of intensive research and international collaboration,” said Jürgen Müller. “I am proud of what we achieved together and know that the center will continue to provide scientific impetus to develop innovative research approaches that will be integrated into the global research strategy of Daiichi Sankyo. I wish my colleagues, especially Veronika, every success in this endeavor.”

Discover the latest trends and insights—explore the Business Insight Journal for up-to-date strategies and industry breakthroughs!

Related posts

Brainomix e-Lung Enables Early Detection of Pulmonary Fibrosis

PR Newswire

Precigen & RRP Foundation to Host 2025 RRP Awareness Day

PR Newswire

Azafaros Starts Phase 3 Trials for Rare Neuro Disorders

Business Wire